{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:52:09Z","timestamp":1780991529094,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.jocn.2009.10.012","type":"journal-article","created":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T03:22:40Z","timestamp":1271042560000},"page":"770-773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The effects of dexmedetomidine dosage on cerebral vasospasm in a rat subarachnoid haemorrhage model"],"prefix":"10.1016","volume":"17","author":[{"given":"Hilal","family":"Ayoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanser","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Hanci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Bahadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Bektas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayca Gorkem","family":"Mungan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isil Ozkocak","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bektas","family":"Acikgoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2009.10.012_bib1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/01.STR.25.7.1342","article-title":"Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage","volume":"24","author":"Broderick","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2009.10.012_bib2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1227\/00006123-198312000-00001","article-title":"Causes of unfavorable outcome after early aneurysm operation","volume":"13","author":"Ljunggren","year":"1983","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2009.10.012_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00006123-199802000-00038","article-title":"Neuroprotective effect of antioxidant, ebselen, in patients with delayed neurological deficits after aneurismal subarachnoid hemorrhage","volume":"42","author":"Saito","year":"1998","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2009.10.012_bib4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/01.WCB.0000125886.48838.7E","article-title":"Signaling pathways for early brain injury after subarachnoid hemorrhage","volume":"24","author":"Kusaka","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jocn.2009.10.012_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00004647-200404000-00007","article-title":"Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage","volume":"24","author":"Zhou","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jocn.2009.10.012_bib6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3171\/jns.1990.72.4.0626","article-title":"The significance of morphological changes in cerebral arteries after subarachnoid hemorrhage","volume":"72","author":"Mayberg","year":"1990","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2009.10.012_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1227\/00006123-199203000-00004","article-title":"The permeability change of major cerebral arteries in experimental vasospasm","volume":"30","author":"Ohta","year":"1992","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2009.10.012_bib8","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3349\/ymj.2003.44.6.955","article-title":"Preventive effects of intracisternal alphatocopherol on cerebral vasospasm in experimental subarachnoid hemorrhage","volume":"44","author":"Kemaloglu","year":"2003","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jocn.2009.10.012_bib9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3171\/jns.1994.80.3.0476","article-title":"Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs","volume":"80","author":"Kajita","year":"1994","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2009.10.012_bib10","first-page":"13","article-title":"The role of lipid peroxidation in the genesis of vasospasm secondary to subarachnoid hemorrhage","volume":"37","author":"Caner","year":"1991","journal-title":"Kobe J Med Sci"},{"key":"10.1016\/j.jocn.2009.10.012_bib11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1227\/00006123-199010000-00013","article-title":"Pharmacological reversibility of experimental cerebral vasospasm","volume":"27","author":"Nakagomi","year":"1990","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2009.10.012_bib12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00004647-200006000-00001","article-title":"Dexmedetomidine-induced stimulation of glutamine oxidation in astrocytes: a possible mechanism for its neuroprotective activity","volume":"20","author":"Huang","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jocn.2009.10.012_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0006-8993(93)90337-M","article-title":"The alpha 2 adrenergic agonist, dexmedetomidine, selectively attenuates ischemia-induced increases in striatal norepinephrine concentrations","volume":"627","author":"Matsumoto","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.jocn.2009.10.012_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000542-199609000-00014","article-title":"Effects of dexmedetomidine on hypoxia-evoked glutamate release and glutamate receptor activity in hippocampal slices","volume":"85","author":"Talke","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jocn.2009.10.012_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00000542-200201000-00026","article-title":"Effects of alpha(2)-adrenoceptor agonists on perinatal excitotoxic brain injury","volume":"96","author":"Laudenbach","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jocn.2009.10.012_bib16","first-page":"524","article-title":"The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S (+) ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats","volume":"96","author":"Engelhard","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jocn.2009.10.012_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00186-7","article-title":"Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia","volume":"372","author":"Jolkkonen","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jocn.2009.10.012_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-3940(97)00585-5","article-title":"Alpha2-adrenoceptor agonist, dexmedetomidine, alters acute gene expression after global ischemia in gerbils","volume":"232","author":"Wittner","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2009.10.012_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jocn.2009.10.012_bib20","first-page":"1126","article-title":"The human serum paraoxonase\/arylesterase polymorphism","volume":"35","author":"Eckerson","year":"1983","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jocn.2009.10.012_bib21","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/01.STR.31.4.901","article-title":"Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage","volume":"31","author":"Naredi","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2009.10.012_bib22","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1179\/016164107X240224","article-title":"Molecular mechanisms of cerebral vasospasm following aneurysmal SAH","volume":"29","author":"Rothoerl","year":"2007","journal-title":"Neurol Res"},{"key":"10.1016\/j.jocn.2009.10.012_bib23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1017\/S031716710000682X","article-title":"Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice","volume":"34","author":"Liu","year":"2007","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jocn.2009.10.012_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.pnpbp.2004.05.006","article-title":"Hypothalamic superoxide dismutase, xanthine oxidase, nitric oxide, and malondialdehyde in rats fed with fish omega-3 fatty acids","volume":"28","author":"Songur","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.jocn.2009.10.012_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.surneu.2007.08.020","article-title":"The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage","volume":"71","author":"Cosar","year":"2009","journal-title":"Surg Neurol"},{"key":"10.1016\/j.jocn.2009.10.012_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(95)00744-B","article-title":"Alpha 2-adrenoceptor agonist, dexmedetomidine, protects against, kainic acid-induced convulsions and neuronal damage","volume":"693","author":"Halonen","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.jocn.2009.10.012_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00000542-199708000-00025","article-title":"Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia","volume":"87","author":"Kuhmonen","year":"1997","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jocn.2009.10.012_bib28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1254\/jphs.SC0050160","article-title":"Hypersensitivity to hydroxyl radicals in rat basilar artery after subarachnoid hemorrhage","volume":"100","author":"Nishihashi","year":"2006","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jocn.2009.10.012_bib29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3171\/jns.1980.53.4.0480","article-title":"Cerebrovascular reactivity to noradrenaline and serotonin following experimental subarachnoid hemorrhage","volume":"53","author":"Lobato","year":"1980","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2009.10.012_bib30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/01.STR.20.7.918","article-title":"Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia in rats","volume":"20","author":"Bromont","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2009.10.012_bib31","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1073\/pnas.87.13.5144","article-title":"Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia\/reperfusion-induced injury to gerbil brain","volume":"87","author":"Oliver","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jocn.2009.10.012_bib32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.expneurol.2005.03.004","article-title":"Activation of noradrenergic transmission by alpha2-adrenoceptor antagonists counteracts deafferentation-induced neuronal death and cell proliferation in the adult mouse olfactory bulb","volume":"194","author":"Veyrac","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jocn.2009.10.012_bib33","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/sj.bjp.0701520","article-title":"Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative, and hypothermic action of dexmedetomidine in transgenic mice","volume":"122","author":"Hunter","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jocn.2009.10.012_bib34","doi-asserted-by":"crossref","first-page":"9950","DOI":"10.1073\/pnas.94.18.9950","article-title":"Substitution of a mutant alpha2a-adrenergic receptor via \u201chit and run\u201d gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo","volume":"94","author":"Lakhlani","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jocn.2009.10.012_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2004.08.044","article-title":"Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype","volume":"502","author":"Ma","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jocn.2009.10.012_bib36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.21.4.577","article-title":"Chronic cerebral blood flow changes following experimental subarachnoid hemorrhage in rats","volume":"21","author":"Kader","year":"1990","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2009.10.012_bib37","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0891-5849(98)00272-X","article-title":"Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants","volume":"26","author":"Aviram","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jocn.2009.10.012_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0306-3623(98)00028-7","article-title":"Human serum paraoxonase","volume":"31","author":"Mackness","year":"1998","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.jocn.2009.10.012_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0009-2797(93)90037-Y","article-title":"Paraoxonase distribution in Caucasian males","volume":"87","author":"Williams","year":"1993","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jocn.2009.10.012_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00041433-199604000-00004","article-title":"Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins","volume":"7","author":"Mackness","year":"1996","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jocn.2009.10.012_bib41","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.neuro.2008.02.004","article-title":"Development of a physiologically based pharmacokinetic and pharmacodynamic model to determine dosimetry and cholinesterase inhibition for a binary mixture of chlorpyrifos and diazinon in the rat","volume":"29","author":"Timchalk","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jocn.2009.10.012_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0021-9150(91)90215-O","article-title":"Serum paraoxonase activity in familial hypercholesterolemia and insulin dependent diabetes mellitus","volume":"86","author":"Mackness","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jocn.2009.10.012_bib43","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","article-title":"Paraoxonase and atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jocn.2009.10.012_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1567-5688(02)00046-6","article-title":"Paraoxonase and coronary heart disease","volume":"3","author":"Mackness","year":"2002","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.jocn.2009.10.012_bib45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1357-4310(99)01546-4","article-title":"Does paraoxonase play a role in susceptibility to cardiovascular disease?","volume":"5","author":"Aviram","year":"1999","journal-title":"Mol Med Today"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586809007310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586809007310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:12:37Z","timestamp":1760821957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586809007310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0967586809007310"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2009.10.012","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of dexmedetomidine dosage on cerebral vasospasm in a rat subarachnoid haemorrhage model","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2009.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}